Resona Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.1M Buy
39,832
+585
+1% +$199K 0.07% 261
2025
Q4
$15.6M Sell
39,247
-2,250
-5% -$996K 0.08% 233
2025
Q3
$18.9M Sell
41,497
-2,203
-5% -$897K 0.09% 208
2025
Q2
$14.2M Buy
43,700
+4,780
+12% +$1.32M 0.07% 267
2025
Q1
$10.5M Buy
38,920
+2,264
+6% +$582K 0.06% 286
2024
Q4
$8.64M Sell
36,656
-921
-2% -$242K 0.05% 327
2024
Q3
$10.3M Sell
37,577
-5,890
-14% -$1.53M 0.06% 296
2024
Q2
$10.6M Sell
43,467
-3,474
-7% -$548K 0.06% 281
2024
Q1
$7.02M Buy
+46,941
New +$7.83M 0.04% 378

Other funds holding ALNY